Hermetica Superfood Encyclopedia
The Short Answer
Carpolobia lutea contains saponins, flavonoids, tannins, alkaloids, polyphenols, and triterpenoids that exert anti-inflammatory effects likely through suppression of inflammatory mediator release and membrane-active cytotoxic mechanisms. In rodent models, the fruit methanol extract at 200 mg/kg inhibited carrageenan-induced paw oedema by 83.66% and xylene-induced ear oedema by 89.85% (P<0.05), outcomes comparable to standard anti-inflammatory reference drugs.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordCarpolobia lutea benefits
Ndela — botanical close-up
Health Benefits
**Anti-inflammatory Activity**
Stem-bark and fruit extracts reduce inflammatory oedema in rodent models, with fruit methanol extract (200 mg/kg) achieving up to 83.66% inhibition of carrageenan paw oedema, attributed to flavonoids, tannins, anthraquinones, and phenolic compounds suppressing inflammatory mediator release.
**Analgesic (Antinociceptive) Effects**: Stem-bark fractions administered at 86
6–173.2 mg/kg demonstrated pain-relieving effects in rodent nociception models that were statistically comparable to indomethacin (10 mg/kg), paracetamol (130 mg/kg), and morphine (5 mg/kg), likely mediated through alkaloids and saponins acting on pain signaling pathways.
**Antimicrobial Properties**
Root chloroform extracts show a minimum inhibitory concentration (MIC) of 25 mg/ml against select Gram-positive bacteria including Enterococcus faecalis, with activity attributed to polyphenols and tannins disrupting bacterial cell wall integrity.
**Antioxidant Capacity**
Polyphenols, flavonoids, and tannins identified in root and leaf extracts are associated with free radical scavenging activity, providing a mechanistic basis for traditional use in managing oxidative stress-associated conditions such as ulcers and infections.
**Gastroprotective and Antiulcer Activity**
Traditional use across Niger Delta communities for stomach ulcers is supported by the presence of saponins and triterpenoids that can modulate gastric mucosal protection and reduce acid-related damage, though direct mechanistic studies remain limited.
**Aphrodisiac and Reproductive Effects**
Saponin fractions have been linked to stimulation of luteinizing hormone release, which may underpin traditional use as a libido enhancer and fertility aid, though this same mechanism constitutes an abortifacient risk in pregnancy.
**Antimalarial and Antipyretic Use**
Ethnomedical records from southern Nigeria document use against malaria and fever; moderate antimalarial activity has been noted in preclinical assessments, with alkaloids and terpenoids considered the primary bioactive contributors.
Origin & History
Natural habitat
Carpolobia lutea is a shrub or small tree native to the tropical rainforest belt of West and Central Africa, with particularly dense populations documented in southern Nigeria, including the Niger Delta region and Cross River State. It thrives in humid, lowland forest understory conditions with well-drained, loamy soils and high annual rainfall typical of the Guinea-Congolian forest zone. The plant is not widely cultivated commercially and is primarily harvested from wild stands by traditional healers, with roots, stems, bark, leaves, and fruits all utilized in ethnomedicine.
“Carpolobia lutea has a deep-rooted history in the traditional medicine systems of southern Nigeria, particularly among the Ibibio, Ijaw, and other Niger Delta ethnic groups, where it is known regionally as Ndela and has been applied for generations to treat gonorrhea, gingivitis, genitourinary infections, infertility, and inflammatory pain conditions. The plant holds cultural significance as both an aphrodisiac and a fertility remedy, with roots and bark prepared as decoctions or chewed directly, reflecting its prominent role in reproductive health ethnomedicine across the region. In ethnobotanical surveys of the Niger Delta, Carpolobia lutea ranks among frequently cited medicinal plants for antiulcer, antidiarrheal, antipyretic, and antimalarial applications, demonstrating broad therapeutic attribution by local healers. Its traditional preparation aligns with modern phytochemical findings, as the hydroalcoholic extraction methods used by traditional practitioners effectively solubilize the alkaloids, saponins, tannins, and flavonoids now identified as pharmacologically active constituents.”Traditional Medicine
Scientific Research
The evidence base for Carpolobia lutea consists entirely of preclinical studies — in vitro antimicrobial assays and rodent pharmacological models — with no published human clinical trials as of current literature. Key quantified findings include 83.66% inhibition of carrageenan paw oedema and 89.85% inhibition of xylene ear oedema with fruit methanol extract at 200 mg/kg (P<0.05), alongside dose-dependent antinociceptive effects of stem-bark fractions (86.6–173.2 mg/kg) compared to standard analgesics in rodent models, though sample sizes and full statistical reporting are not detailed in available sources. Antimicrobial studies using agar dilution methods report a chloroform root extract MIC of 25 mg/ml against select bacteria, with no activity against Gram-negative organisms such as Escherichia coli and Pseudomonas aeruginosa or against Candida albicans. The overall evidence quality is low by clinical standards due to the absence of randomized controlled trials, standardized extract preparations, pharmacokinetic data, and human bioavailability studies, limiting extrapolation of preclinical findings to human supplementation.
Preparation & Dosage
Traditional preparation
**Traditional Hydroalcoholic Decoction (Roots/Stems)**
Roots or stem bark are boiled in water or soaked in ethanol-water mixtures and consumed orally; no standardized volumes or frequencies are documented in ethnomedicinal literature.
**Root Extract (Antimicrobial, Preclinical)**
25 mg/ml in vitro; no human-equivalent dose is established
Chloroform root extracts demonstrate antibacterial activity at MIC .
**Stem-Bark Extract (Antinociceptive, Preclinical)**
2 mg/kg body weight in rodent models produced analgesic effects comparable to reference drugs; human equivalents using body surface area scaling have not been validated
Oral doses of 86.6–173..
**Fruit Extract (Anti-inflammatory, Preclinical)**
200 mg/kg oral in rodent models achieved maximum oedema inhibition (83
Methanol fruit extract at .66% paw, 89.85% ear); no human dosing guidelines exist.
**Standardization**
No commercial standardized extract preparations or certified supplement forms (capsules, tablets, tinctures) are currently available; all studied forms are laboratory-grade crude or fractionated extracts.
**Timing**
Traditional use typically involves daily decoctions, but no clinical data support specific dosing intervals or treatment durations.
Nutritional Profile
Carpolobia lutea is not consumed as a food source and lacks a conventional macronutrient or micronutrient profile in the nutritional literature. Phytochemical analyses of fruit extracts by GC-MS identify fatty acid constituents including oleic acid, n-hexadecanoic acid (palmitic acid), cis-vaccenic acid, and cis-13-octadecenoic acid, alongside the triterpene hydrocarbon squalene and the long-chain alkane nonacosane, suggesting a lipid-rich fruit fraction. Secondary metabolite classes across plant parts include saponins, alkaloids, tannins, anthraquinones, flavonoids, cardiac glycosides, terpenoids, and simple sugars; however, exact concentrations in mg/g of dried plant material have not been quantified in any published phytochemical study. Bioavailability of active constituents from oral ingestion in humans is entirely unstudied, and the presence of tannins may reduce oral absorption of co-ingested minerals through chelation.
How It Works
Mechanism of Action
The anti-inflammatory and analgesic activities of Carpolobia lutea are primarily attributed to flavonoids, tannins, anthraquinones, and phenolic compounds that collectively inhibit the biosynthesis and release of pro-inflammatory mediators such as prostaglandins, histamine, and bradykinin, thereby reducing vascular permeability and oedema formation, as evidenced in carrageenan and xylene rodent models. Triterpenoid saponins exert membrane-permeabilizing effects on microbial and host cell membranes, disrupting pathogen integrity and modulating immune signaling, while also stimulating pituitary luteinizing hormone release through a mechanism that may involve steroidogenic pathway activation. Alkaloids present in root and stem-bark fractions likely contribute to antinociception through interactions with central and peripheral pain pathway components, though specific receptor targets such as opioid or GABA receptors have not been formally characterized in published studies. Polyphenolic compounds including tannins contribute antimicrobial action by precipitating bacterial surface proteins and chelating essential metal ions required for microbial enzyme function, particularly active against Gram-positive organisms.
Clinical Evidence
No human clinical trials have been conducted on Carpolobia lutea in any of its extract forms, meaning there are no randomized controlled trial-derived effect sizes, safety data, or dose-response relationships established in human populations. All pharmacological outcomes derive from animal experiments, primarily rodent oedema, nociception, and infection models, where extracts demonstrated meaningful anti-inflammatory and analgesic effects at oral doses of 86.6–200 mg/kg body weight. The fruit methanol extract showed the strongest anti-inflammatory signal at 200 mg/kg, achieving oedema inhibition exceeding 83%, while stem-bark fractions exhibited antinociceptive potency approaching that of morphine and indomethacin in rodent assays, outcomes that warrant human investigation but cannot yet be directly translated to clinical recommendations. Confidence in therapeutic outcomes for human use remains very low, and all health claims are currently supported only by traditional ethnomedicinal use and animal pharmacology data.
Safety & Interactions
Human safety data for Carpolobia lutea are absent from the published literature, with toxicological characterization limited to a noted observation of moderate toxicity in preclinical antimalarial studies; formal LD50 values, subchronic toxicity studies, or clinical adverse event data have not been reported. Saponin constituents are mechanistically linked to abortifacient effects through luteinizing hormone stimulation, making use during pregnancy a clear contraindication based on pharmacological evidence; use during lactation should similarly be avoided given the absence of safety data in these populations. No formal drug interaction studies exist, but the presence of cardiac glycosides warrants caution regarding potential additive effects with digoxin or other cardioactive medications, and tannin content may interfere with absorption of iron supplements, antibiotics, or alkaloid-based drugs when taken concurrently. Given that all dosing data originate from animal models and no maximum safe human dose has been established, use of Carpolobia lutea preparations outside of traditional contexts or formal research settings cannot be considered evidence-based.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Carpolobia lutea G.DonNdelaPolygalaceae shrubcattle sticknsofop
Frequently Asked Questions
What is Ndela (Carpolobia lutea) used for in traditional medicine?
In southern Nigerian traditional medicine, Ndela is used to treat gonorrhea, gingivitis, genitourinary infections, stomach ulcers, malaria, infertility, inflammatory pain, and fever, and is also applied as an aphrodisiac and libido enhancer. Roots, stem bark, leaves, and fruits are prepared as decoctions or hydroalcoholic extracts by traditional healers, particularly among Ibibio and Niger Delta communities.
Does Carpolobia lutea have proven anti-inflammatory effects?
Preclinical rodent studies show that the fruit methanol extract at 200 mg/kg orally inhibits carrageenan-induced paw oedema by 83.66% and xylene-induced ear oedema by 89.85% (P<0.05), effects attributed to flavonoids, tannins, anthraquinones, and phenolic compounds. However, no human clinical trials have been conducted, so these findings cannot yet be directly applied to human health recommendations.
Is Carpolobia lutea safe to use during pregnancy?
Carpolobia lutea is contraindicated during pregnancy because its saponin constituents have been linked to abortifacient properties through stimulation of luteinizing hormone release, which can adversely affect pregnancy maintenance. No human safety data are available, and the absence of clinical toxicology studies means risks during lactation are also unknown; pregnant or breastfeeding individuals should avoid this herb entirely.
What are the active compounds in Carpolobia lutea root?
Phytochemical screening of Carpolobia lutea root extracts identifies saponins, alkaloids, tannins, anthraquinones, flavonoids, cardiac glycosides, terpenoids, and simple sugars as primary secondary metabolite classes. Chloroform and methanol fractions are particularly rich in these compounds, with saponins and polyphenols considered the most pharmacologically significant for anti-inflammatory and antimicrobial effects, though exact concentrations in mg/g have not been quantified in published studies.
What is the effective dose of Carpolobia lutea for pain relief?
In rodent antinociception models, stem-bark fractions of Carpolobia lutea administered orally at 86.6–173.2 mg/kg body weight produced analgesic effects statistically comparable to indomethacin (10 mg/kg) and paracetamol (130 mg/kg). No equivalent human dose has been established, as no clinical trials have been performed, and direct dose conversion from animal studies is not scientifically valid without human pharmacokinetic data.
What is the most bioavailable form of Ndela (Carpolobia lutea) for anti-inflammatory benefits?
Fruit methanol extracts of Carpolobia lutea demonstrate superior bioavailability and efficacy compared to other preparations, with research showing the fruit extract achieving up to 83.66% inhibition of inflammatory edema in animal models. The methanol extraction process efficiently isolates the active flavonoids, tannins, and anthraquinones responsible for anti-inflammatory effects. Standardized fruit extracts are therefore likely more effective than whole plant powders or stem-bark preparations alone for maximizing anti-inflammatory benefits.
How does Ndela (Carpolobia lutea) compare to other traditional African herbs for pain and inflammation?
Carpolobia lutea stands out among African ethnobotanicals due to its dual analgesic and anti-inflammatory mechanisms—the stem-bark provides antinociceptive activity while fruit extracts deliver potent inflammatory edema reduction through multiple phytochemical classes. Unlike single-compound pain relievers, Ndela's complex array of flavonoids, tannins, and anthraquinones work synergistically to suppress inflammatory mediator release at the source. This multi-targeted approach makes it distinctive compared to herbs relying primarily on alkaloids or essential oils.
What does current research evidence show about Ndela (Carpolobia lutea)'s effectiveness, and what gaps remain?
Existing research demonstrates strong in vivo efficacy for Carpolobia lutea's anti-inflammatory and analgesic properties in rodent models, with quantified outcomes such as 83.66% paw edema inhibition providing measurable evidence of potency. However, clinical trials in humans remain limited, and the exact mechanisms by which stem-bark fractions exert analgesic effects require further characterization beyond current understanding. More pharmacokinetic studies and randomized controlled trials are needed to establish optimal human dosing and to confirm whether animal model results translate to therapeutic benefit in clinical settings.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ndela-carpolobia-lutea curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
